Seattle Genetics reported $3.07B in Equity Capital and Reserves for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Agios Pharmaceuticals AGIO:US $ 1291.97M 102.79M
Bayer BAYN:GR € 33020M 1917M
Bluebird Bio BLUE:US $ 374.28M 496.25M
Celldex Therapeutics CLDX:US $ 398.1M 21.38M
Daiichi Sankyo 4568:JP Y 1331220M 18992M
Eisai 4523:JP Y 734788M 4452M
Genmab GEN:DC DK 22719M 523M
Immunogen IMGN:US $ 306.47M 19.12M
Mirati Therapeutics MRTX:US $ 1249.28M 147.76M
Nektar Therapeutics NKTR:US $ 679.51M 122.03M
Novartis NOVN:VX SF 67655M 10884M
Spectrum Pharmaceuticals SPPI:US $ 55.26M 7.7M
Teva Pharmaceutical TEVA:IT 10.28B 189M
Xencor XNCR:US $ 763.02M 29.52M